For patients with central nervous system (CNS) relapse, intraventricular radioimmunotherapy using I131-3F8 or I131-8H9 (targeting B7H3, omburtamab, Y-mAbs) may help to clear the neuroblastoma cells in the cerebrospinal fluid [78]. Here, CD276 is linked to neuroblastoma.